CoChat

DBCSMOTE: a clustering-based oversampling technique for data-imbalanced warfarin dose prediction

Open access
Tao, Yanyun, Zhang, Yuzhen, Jiang, Bin · 2020 · BMC Medical Genomics

The DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.

Abstract

Background: Vitamin K antagonist (warfarin) is the most classical and widely used oral anticoagulant with assuring anticoagulant effect, wide clinical indications and low price. Warfarin dosage requirements of different patients vary largely. For warfarin daily dosage prediction, the data imbalance in dataset leads to inaccurate prediction on the patients of rare genotype, who usually have large stable dosage requirement. To balance the dataset of patients treated with warfarin and improve the predictive accuracy, an appropriate partition of majority and minority groups, together with an oversampling method, is required. Method: To solve the data-imbalance problem mentioned above, we developed a clustering-based oversampling technique denoted as DBCSMOTE, which combines density-based spatial clustering of application with noise (DBCSCAN) and synthetic minority oversampling technique (SMOTE). DBCSMOTE automatically finds the minority groups by acquiring the association between samples in terms of the clinical features/genotypes and the warfarin dosage, and creates an extended dataset by adding the new synthetic samples of majority and minority groups. Meanwhile, two ensemble models, boosted regression tree (BRT) and random forest (RF), which are built on the extended dataset generateed by DBCSMOTE, accomplish the task of warfarin daily dosage prediction. Results: DBCSMOTE and the comparison methods were tested on the datasets derived from our Hospital and International Warfarin Pharmacogenetics Consortium (IWPC). As the results, DBCSMOTE-BRT obtained the highest R -squared ( R 2 ) of 0.424 and the smallest mean squared error (mse) of 1.08. In terms of the percentage of patients whose predicted dose of warfarin is within 20% of the actual stable therapeutic dose (20%- p ), DBCSMOTE-BRT can achieve the largest value of 47.8% among predictive models. The more important thing is that DBCSMOTE saved about 68% computational time to achieve the same or better performance than the Evolutionary SMOTE, which was the best oversampling method in warfarin dose prediction by far. Meanwhile, in warfarin dose prediction, it is discovered that DBCSMOTE is more effective in integrating BRT than RF for warfarin dose prediction. Conclusion: Our finding is that the genotypes, CYP2C9 and VKORC1, no doubt contribute to the predictive accuracy. It was also discovered left atrium diameter, glutamic pyruvic transaminase and serum creatinine included in the model actually improved the predictive accuracy; When congestive heart failure, diabetes mellitus and valve replacement were absent in DBCSMOTE-BRT/RF, the predictive accuracy of DBCSMOTE-BRT/RF decreased. The oversampling ratio and number of minority clusters have a large impact on the effect of oversampling. According to our test, the predictive accuracy was high when the number of minority clusters was 6 ~ 8. The oversampling ratio for small minority clusters should be large (> 1.2) and for large minority clusters should be small (< 0.2). If the dataset becomes larger, the DBCSMOTE would be re-optimized and its BRT/RF model should be re-trained. DBCSMOTE-BRT/RF outperformed the current commonly-used tool called Warfarindosing. As compared to Evolutionary SMOTE-BRT and RF models, DBCSMOTE-BRT and RF models take only a small computational time to achieve the same or higher performance in many cases. In terms of predictive accuracy, RF is not as good as BRT. However, RF still has a powerful ability in generating a highly accurate model as the dataset increases; the software “WarfarinSeer v2.0” is a test version, which packed DBCSMOTE-BRT/RF. It could be a convenient tool for clinical application in warfarin treatment.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1186/s12920-020-00781-2

Cites

33 of 33 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig. 1 minority groups and the effect of minority on predictive accuracy
Fig. 1 minority groups and the effect of minority on predictive accuracyCC BY · PubMed Central
Fig. 2 mse, R-squared and 20%-p of different parameters for DBCSMOTE
Fig. 2 mse, R-squared and 20%-p of different parameters for DBCSMOTECC BY · PubMed Central
Fig. 3 average mse of methods over five test sets
Fig. 3 average mse of methods over five test setsCC BY · PubMed Central
Fig. 4 average R2 of methods over five test sets
Fig. 4 average R2 of methods over five test setsCC BY · PubMed Central
Fig. 5 average 20%-p of methods
Fig. 5 average 20%-p of methodsCC BY · PubMed Central
Fig. 6 DBCSMOTE vs ESMOTE in mse and computational time
Fig. 6 DBCSMOTE vs ESMOTE in mse and computational timeCC BY · PubMed Central
Fig. 7 comparison between DBCSMOTE-BRT/RF models with and without LA, ALT and SCr (a) mse comparison (b) mae comparison (c) R2 comparison (d) 20%-p comparison
Fig. 7 comparison between DBCSMOTE-BRT/RF models with and without LA, ALT and SCr (a) mse comparison (b) mae comparison (c) R2 comparison (d) 20%-p comparisonCC BY · PubMed Central
Fig. 8 comparison between DBCSMOTE-BRT/RF models with and without CHF, DM and VR (a) mse comparison (b) mae comparison (c) R2 comparison (d) 20%-p comparison
Fig. 8 comparison between DBCSMOTE-BRT/RF models with and without CHF, DM and VR (a) mse comparison (b) mae comparison (c) R2 comparison (d) 20%-p comparisonCC BY · PubMed Central
Fig. 9 DBCSMOTE extending training set, parameter optimization of DBCSMOTE and testing process
Fig. 9 DBCSMOTE extending training set, parameter optimization of DBCSMOTE and testing processCC BY · PubMed Central
Fig. 10 finding samples of the minority class according to the density
Fig. 10 finding samples of the minority class according to the densityCC BY · PubMed Central
Fig. 11 warfarin dosing predictive tool “WarfarinSeer” encapsulated DBCSMOTE (a) software interface (b) actual dose vs predicted dose
Fig. 11 warfarin dosing predictive tool “WarfarinSeer” encapsulated DBCSMOTE (a) software interface (b) actual dose vs predicted doseCC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 33 references

Research works printed but not linked: 1

  1. Byrne SCP, Barry A, Graham I, et.al, Using Neural Nets for Decision Support in Prescription and Outcome Prediction in Anticoagulation Drug Therapy, The Fifth Workshop on Intelligent Data Analysis in Medicine and Pharmacology (IDAMAP-2000) Workshop Notes of the 14th European Conference on Artificial Intelligence (ECAI-2000). 2000; 576:582.

Cited by

See all 20

Metadata

Authors
Tao, Y., Zhang, Y., & Jiang, B.
Affiliations
  • Soochow University (CN)
  • First Affiliated Hospital of Soochow University (CN)
Corresponding author
Zhang, Yuzhen
Venue
BMC Medical Genomics
Published
2020-10
Volume
13
Issue
S10
Pages
152-152
ISSN
1755-8794 (ISSN-L)
OpenAlex
W3093905432
Cited by
20
References
32
Citations by year
2026: 4 · 2025: 4 · 2024: 4 · 2023: 2 · 2022: 2 · 2021: 4
FWCI
0.79
Type
journal article
Language
en
Open access
Licence
Locations
  • BMC Medical Genomics (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
  • National Natural Science Foundation of China (61872259, 81700298)
  • China Postdoctoral Science Foundation
  • Soochow University
  • Jiangsu Planned Projects for Postdoctoral Research Funds
Topics
  • Physical Sciences › Computer Science › Artificial Intelligence › Imbalanced Data Classification Techniques
  • Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Pharmacogenetics and Drug Metabolism
  • Health Sciences › Health Professions › Health Information Management › Artificial Intelligence in Healthcare
Keywords
warfarin dose prediction, class imbalance, oversampling, SMOTE, anticoagulation, CYP2C9, VKORC1, genotypes, boosted regression trees, random forest, therapeutic dose, clinical features, left atrial diameter, alanine aminotransferase, serum creatinine, congestive heart failure
MeSH terms
Algorithms, Anticoagulants, Female, Humans, Male, Models, Biological, Pharmacogenetics, Polymorphism, Genetic, Warfarin, Cluster Analysis, Computational Biology, Drug Dosage Calculations, Vitamin K Epoxide Reductases, Cytochrome P-450 CYP2C9

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: DBCSMOTE: a clustering-based oversampling technique for data-imbalanced warfarin dose prediction. https://app.cochat.ai/papers/10.1186/s12920-020-00781-2
The paper
Tao, Y., Zhang, Y., & Jiang, B. (2020). DBCSMOTE: a clustering-based oversampling technique for data-imbalanced warfarin dose prediction. BMC Medical Genomics. https://doi.org/10.1186/s12920-020-00781-2

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.